Otsu, Japan

Ryutaro Suzuki

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toray Industries, Inc.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryutaro Suzuki. Retrieved from https://idiyas.com/inventor/ryutaro-suzuki-hzecmwlh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Ryutaro Suzuki

Introduction: Ryutaro Suzuki is a notable inventor based in Otsu, Japan, recognized for his contributions to the field of medicinal chemistry. With a focus on developing innovative compounds, his work has pivotal implications for treating various diseases, particularly inflammatory bowel disease.

Latest Patents: One of Ryutaro Suzuki's significant achievements is his patent for a glycine derivative. This compound demonstrates excellent therapeutic and prophylactic effects against inflammatory bowel disease. Notably, it has superior absorption and in vivo stability when administered orally compared to conventional compounds, allowing for prolonged therapeutic efficacy.

Career Highlights: Ryutaro Suzuki is currently affiliated with Toray Industries, Inc., a prominent company known for its cutting-edge research and development in various industries. His dedication to innovation and quality in his work is evident through his successful patent.

Collaborations: Throughout his career, Ryutaro has collaborated with esteemed colleagues such as Noriyuki Hirano and Hideki Inoue. These collaborations have been instrumental in advancing research and contributing to the development of impactful inventions in the field.

Conclusion: In conclusion, Ryutaro Suzuki stands out as a distinguished inventor whose work on glycine derivatives has the potential to change the landscape of treatment for inflammatory bowel disease. His career at Toray Industries and collaborations with notable peers underscore his commitment to driving innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…